Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Inozyme Pharma, Inc. (INZY)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 9.3% stake in Inozyme Pharma, Inc. |
| 02/14/2023 |
SC 13G/A
| Rock Springs Capital Management LP reports a 7.6% stake in Inozyme Pharma, Inc. |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2023 |
SC 13G/A
| Flynn James E reports a 0% stake in Inozyme Pharma, Inc. |
| 02/09/2023 |
SC 13G/A
| ADAGE CAPITAL PARTNERS GP, L.L.C. reports a 7.7% stake in Inozyme Pharma, Inc. |
| 02/14/2022 |
SC 13G/A
| Pivotal bioVenture Partners Fund I, L.P. reports a 6.7% stake in Inozyme Pharma, Inc. |
| 02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2022 |
SC 13G/A
| ADAGE CAPITAL PARTNERS GP, L.L.C. reports a 6.8% stake in Inozyme Pharma, Inc. |
| 02/07/2022 |
SC 13G/A
| New Enterprise Associates 15, L.P. has filed a Schedule 13D for Inozyme Pharma, Inc. |
| 11/15/2021 |
SC 13G/A
| RA CAPITAL MANAGEMENT, L.P. reports a 0% stake in INOZYME PHARMA, INC. |
|
|